Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
Abroad (travel likely)RecruitingPHASE2
Conditions
Cardiac Disease · Surgery · Bleeding
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
North Shore University Hospital, Manhasset, New York, United States
Contact: Study coordinator (Kristine McGowan)
Study leads
Pey-Jen Yu
Principal Investigator
Northwell Health